全文获取类型
收费全文 | 24108篇 |
免费 | 2704篇 |
国内免费 | 1796篇 |
专业分类
电工技术 | 2055篇 |
综合类 | 2585篇 |
化学工业 | 2998篇 |
金属工艺 | 1458篇 |
机械仪表 | 1667篇 |
建筑科学 | 1690篇 |
矿业工程 | 945篇 |
能源动力 | 712篇 |
轻工业 | 2706篇 |
水利工程 | 847篇 |
石油天然气 | 703篇 |
武器工业 | 408篇 |
无线电 | 2573篇 |
一般工业技术 | 1895篇 |
冶金工业 | 1704篇 |
原子能技术 | 318篇 |
自动化技术 | 3344篇 |
出版年
2024年 | 156篇 |
2023年 | 371篇 |
2022年 | 984篇 |
2021年 | 1212篇 |
2020年 | 862篇 |
2019年 | 636篇 |
2018年 | 683篇 |
2017年 | 754篇 |
2016年 | 693篇 |
2015年 | 1060篇 |
2014年 | 1326篇 |
2013年 | 1603篇 |
2012年 | 1951篇 |
2011年 | 1969篇 |
2010年 | 2018篇 |
2009年 | 1805篇 |
2008年 | 1856篇 |
2007年 | 1808篇 |
2006年 | 1543篇 |
2005年 | 1209篇 |
2004年 | 866篇 |
2003年 | 588篇 |
2002年 | 504篇 |
2001年 | 546篇 |
2000年 | 367篇 |
1999年 | 156篇 |
1998年 | 304篇 |
1997年 | 196篇 |
1996年 | 137篇 |
1995年 | 68篇 |
1994年 | 55篇 |
1993年 | 58篇 |
1992年 | 22篇 |
1991年 | 25篇 |
1990年 | 20篇 |
1989年 | 26篇 |
1988年 | 19篇 |
1987年 | 19篇 |
1986年 | 11篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 12篇 |
1977年 | 18篇 |
1976年 | 42篇 |
1972年 | 2篇 |
1959年 | 10篇 |
1951年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 1 毫秒
31.
32.
33.
34.
35.
The technology of trailing peening is a kind of promisingly bran-new technology which can be used to control weldingstress and distortion of Ti alloy thin plate. Control of TC4 Ti alloy thn plate welding stress and distortion underthe condition of convent 相似文献
36.
37.
38.
39.
The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer
BACKGROUND: The efficacy of squamous cell carcinoma antigen (SCC-Ag) in laryngeal cancer to predict those patients who will relapse after primary treatment (surgery or radiotherapy) and its utility to detect relapses early and thereby increase salvage rates and cure were assessed. METHODS: Sixty healthy donors and 168 patients with laryngeal cancer were included in this prospective trial. Squamous cell carcinoma antigen was measured at diagnosis in all patients, 24 hours and 1 week after surgery in 113 patients and every 10 Gy of administered dose and 2 weeks after treatment in 49 patients primarily referred to radiotherapy. The marker was determined every 3-6 months during follow-up. All patients who relapsed had SCC-Ag studies before and after salvage treatment. RESULTS: The selected cut-off value was 1.5 ngr/ml (mean value in control group, 0.65 + 2 standard deviation [0.38]). Seventy-eight percent of patients with cancer had elevated SCC-Ag values at diagnosis. Squamous cell carcinoma antigen was statistically related to TNM categories (T, P < 0.04; N, P < 0.05; Stage, P < 0.01). Seventy-five percent of those patients with previously elevated pretreatment values normalized after treatment. Incomplete surgical resection (P < 0.0001) or persistence of the disease after radiotherapy (P < 0.01) were related to high posttreatment values. Squamous cell carcinoma antigen was elevated in 88% of the patients who relapsed. In 55% of the recurrences, SCC-Ag was elevated 3 months before pathologic confirmation of relapse. Salvage by surgery or radiotherapy was effective in 70% of the patients. Squamous cell carcinoma antigen posttreatment values were the most important factor in predicting disease free survival (DFS) (P < 0.0001) and overall survival (P < 0.03). CONCLUSIONS: Squamous cell carcinoma antigen is an excellent marker of residual disease after primary treatment that can lead to the addition of other therapeutic procedures (surgery and postoperative radiotherapy). The absence of posttreatment SCC-Ag is the best predictor of DFS, its presence detects recurrence in early stages, permitting salvage of an increased proportion of patients primarily referred for palliative treatment. 相似文献
40.
Phenotypic analysis of antigen-specific T lymphocytes 总被引:4,自引:0,他引:4
JD Altman PA Moss PJ Goulder DH Barouch MG McHeyzer-Williams JI Bell AJ McMichael MM Davis 《Canadian Metallurgical Quarterly》1996,274(5284):94-96
Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens. 相似文献